Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / *W EXP 09/02/202
-
Total 13F shares
-
3,413,888
-
Share change
-
+793,568
-
Total reported value
-
$1,011,637
-
Price per share
-
$0.30
-
Number of holders
-
15
-
Value change
-
+$237,436
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of ROCKET PHARMACEUTICALS, INC. - *W EXP 09/02/202 (RCKTW) as of Q1 2024
As of 31 Mar 2024,
ROCKET PHARMACEUTICALS, INC. - *W EXP 09/02/202 (RCKTW) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,413,888 shares.
The largest 10 holders included
Altium Capital Management LP, Walleye Capital LLC, Sio Capital Management, LLC, CITADEL ADVISORS LLC, RTW INVESTMENTS, LP, Fort Baker Capital Management LP, JPMORGAN CHASE & CO, SILVERARC CAPITAL MANAGEMENT, LLC, Affinity Asset Advisors, LLC, and LMR Partners LLP.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.